Pathway Financial Advisers’s iShares US Healthcare Providers ETF IHF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,316
Closed -$65K 246
2025
Q3
$65K Buy
+1,316
New +$60.1K 0.02% 215
2025
Q1
Sell
-1,309
Closed -$62.8K 277
2024
Q4
$62.8K Buy
1,309
+3
+0.2% +$158 0.02% 217
2024
Q3
$74.6K Buy
1,306
+2
+0.2% +$112 0.03% 164
2024
Q2
$68.3K Buy
1,304
+2
+0.2% +$105 0.02% 206
2024
Q1
$71K Buy
1,302
+2
+0.2% +$106 0.03% 207
2023
Q4
$68.3K Buy
1,300
+5
+0.4% +$253 0.03% 204
2023
Q3
$63.7K Buy
+1,295
New +$65.7K 0.03% 214
2023
Q1
$64K Buy
1,295
+5
+0.4% +$257 0.03% 216
2022
Q4
$69.2K Buy
+1,290
New +$69.3K 0.03% 219

Other funds holding IHF

Pathway Financial Advisers's IHF Position: Q4 2025 in Review

Pathway Financial Advisers sold out of iShares US Healthcare Providers ETF (IHF) in Q4 2025, closing a stake of 1,316 shares — an estimated $65K sold.

Pathway Financial Advisers first reported a position in IHF in Q4 2022 and held it in 9 quarters. The position peaked at $74.6K in Q3 2024. 198 funds tracked by Wall St. Rank hold IHF as of Q4 2025.

  • Pathway Financial Advisers reported no remaining iShares US Healthcare Providers ETF position as of Q4 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 1,316 iShares US Healthcare Providers ETF shares in Q4 2025, an estimated $65K.
  • Pathway Financial Advisers first reported a position in iShares US Healthcare Providers ETF in Q4 2022 and held it in 9 quarters.
  • Pathway Financial Advisers's iShares US Healthcare Providers ETF position peaked at $74.6K in Q3 2024.
  • 198 funds tracked by Wall St. Rank held iShares US Healthcare Providers ETF as of Q4 2025.

Based on Pathway Financial Advisers's 13F filing for Q4 2025, filed 6 Feb 2026.